ArthroCare will pay $30 million and cooperate in federal prosecutions of its former executives under a deferred prosecution agreement inked with the Department of Justice Jan. 7.
The firm also must establish a compliance program to detect and prevent fraudulent activity, including the improper accounting and billing practices that led to the DOJ investigation and separate ongoing...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?